Industry
Funding Opportunities
In June 2006, SNM launched the Bench to Bedside campaign designed to raise $5,000,000 over a five-year period for promoting the critical role molecular imaging plays in patient care. GE Healthcare helped jump-start the initiative with a significant pledge, followed by generous support from Bristol-Myers Squibb Medical Imaging, Siemens Medical Solutions USA, Philips, FluoroPharma, IBA Molecular, MDS Nordion, Cardinal Health, Mallinckrodt, Inc., and Molecular Insight Pharmaceuticals. Total corporate investment now stands at $3,835,000 and member gifts and pledges, supported by the Education and Research Foundation (ERF) for SNM, have totaled more than $110,000.
We invite you to learn more about this important endeavor and invest in the future of your profession with a donation to the campaign by visiting the campaign website.